Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases
A. Joannes (Rennes, France), C. Morzadec (Rennes, France), F. Llamas Gutierrez (Rennes, France), D. Chiforeanu (Rennes, France), B. Richard De Latour (Rennes, France), L. Wollin (Biberach an der Riss, Germany), S. Jouneau (Rennes, France), L. Vernhet (Rennes, France)
Source: Virtual Congress 2020 – Translational therapeutic advances
Session: Translational therapeutic advances
Session type: E-poster session
Number: 3355
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Joannes (Rennes, France), C. Morzadec (Rennes, France), F. Llamas Gutierrez (Rennes, France), D. Chiforeanu (Rennes, France), B. Richard De Latour (Rennes, France), L. Wollin (Biberach an der Riss, Germany), S. Jouneau (Rennes, France), L. Vernhet (Rennes, France). Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases. 3355
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: